Back to Trades
Collins Helen Louise
InsiderCIK 0001701247
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 12
- Buy transactions
- 0
- Sell transactions
- 23
- Companies
- 2
- Active
- 2026
Across 12 filings between 2026, Collins Helen Louise has disclosed $9.4M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $4.4M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
12 loaded
| Oct 21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Sell | $192.3K |
| Sep 21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Sell | $251.8K |
| Aug 19 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Sell | $292.9K |
| Jul 21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Sell | $263.4K |
| Jun 22 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Sell | $219.0K |
| Jun 4 | KURA Kura Oncology, Inc. | Collins Helen Louise | Insider | Award | $306.9K |
| May 20 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Sell | $199.0K |
| Apr 21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Sell | $238.4K |
| Mar 27 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Sell | $1.4M |
| Mar 19 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Sell | $138.8K |
| Feb 19 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Sell | $1.2M |
| Feb 17 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise | Insider | Grant | $4.1M |
12 filings